Samsrita Labs Share Price Today | Stock Price & Samsrita Labs Share Screener
As of October 5, 2026, the live Samsrita Labs share price (BSE: SAMSRITA) is ₹11.35, down 3.49% from the previous close, with shares trading between ₹11.18 and ₹11.99 in today's trading session, and a 52-week range of ₹10.60–₹24.31. Check SAMSRITA annual price range for the annual price range and momentum. Use the Samsrita Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Samsrita Labs opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Samsrita Labs Share Price Chart
Track the current stock price of Samsrita Labs with an interactive chart. Analyse SAMSRITA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Samsrita Labs stock quote in one place.
The quote of ₹11.35 sits between the 52-week low of ₹10.60 and the 52-week high of ₹24.31, and the latest session moved -3.49% from the previous close.
Samsrita Labs Company Profile - Fundamental Screener
Screen Samsrita Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAMSRITA shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE579N01018.
Company Details
Classification
Identifiers and Leadership
Samsrita Labs Balance Sheet Screener
Screen SAMSRITA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹14, down from ₹16 in 2025.
Latest statistics put total assets at ₹14 and shareholder funds at ₹12, with a leverage ratio of 0.17.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 14 | 16 | 16 | 16 | 17 | 17 | 28 | 26 | 23 | 19 |
| Current Assets | 3 | 6 | 6 | 6 | 7 | 7 | 7 | 6 | 4 | 3 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 12 | 12 | 12 | 13 | 13 | 11 | 16 | 16 | 16 | 12 |
| Share Capital | 23 | 15 | 15 | 15 | 15 | 15 | 15 | 14 | 12 | 10 |
| Reserves & Surplus | -11 | -3 | -3 | -2 | -2 | -4 | -3 | -2 | -2 | -2 |
Samsrita Labs Income Statement Screener - Profit & Revenue Analysis
Screen Samsrita Labs income statement and profit fundamentals. Analyze SAMSRITA quarterly results. Samsrita Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹0 and net profit was ₹0, equal to earnings per unit of ₹-0.08.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-Mar, shows revenue of ₹0 and net profit of ₹-1.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2021-Sept | 2021-Jun | 2021-Mar | 2020-Dec | 2020-Sept | 2020-Jun | 2020-Mar | 2019-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Expenses | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 0 | 0 | -3 | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Operating Profit % | 0.00% | -750.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3100.00% | -221.00% | -110.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 0 | 0 | -3 | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -1 | -3 | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | -0.08 | -0.06 | -1.29 | -2.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.03 | 0.09 | -0.13 | -0.19 | -0.19 | -0.26 | -0.28 |
Samsrita Labs Cash Flow Screener - Liquidity Fundamentals
Screen SAMSRITA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹4, and net cash flow was an inflow of ₹2.
Over the same period, investing activities provided ₹3 and financing activities provided ₹3.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -4 | 0 | 0 | 1 | 0 | 0 | -1 | -3 | -3 | 0 |
| Investing Activities | 3 | 0 | 0 | 0 | 0 | 0 | -1 | -2 | -1 | -1 |
Financing and Net Cash | ||||||||||
| Financing Activities | 3 | 0 | 0 | -1 | 0 | 1 | 2 | 4 | 5 | 1 |
| Net Cash Flow | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Samsrita Labs Shareholding Pattern Screener
See Samsrita Labs shareholding pattern with promoter, FII, and DII holdings. Check Samsrita Labs promoter holding and ownership changes for SAMSRITA on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 25.44%, foreign institutions 0.00%, domestic institutions 0.00% and the public 70.48%, spread across 2,441 shareholders.
The shareholder count was 2,441 in 2026-Mar, compared with 2,506 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Jul | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 25.44% | 25.44% | 49.27% | 48.25% | 31.41% | 31.41% | 25.44% | 52.87% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 70.48% | 70.43% | 44.75% | 45.58% | 64.57% | 64.54% | 70.50% | 41.15% |
| Other Holding | 4.08% | 4.14% | 5.99% | 6.17% | 4.02% | 4.05% | 4.06% | 5.99% |
| Shareholder Count | 2,441 | 2,506 | 2,608 | 2,478 | 2,499 | 2,441 | 2,436 | 2,115 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Samsrita Labs. Samsrita Labs dividend yield can be compared with peers and other stocks in the market.
Samsrita Labs Stock Index Membership - Nifty & Sensex
See which indices include Samsrita Labs stock. Check SAMSRITA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Samsrita Labs Market Events Screener - Corporate Actions
Get Samsrita Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Samsrita Labs stock events that may affect SAMSRITA share price, along with derivatives, futures and options activity and sector gainers.
13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 13, 2026, with a record date of August 13, 2026.
It is followed by Annual General Meeting dated August 10, 2026 and Quarterly Result Announcement dated May 29, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 5.14% |
| 2026-08-10 | 2026-08-10 | Annual General Meeting | NA | -2.48% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -12.93% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 7.85% |
| 2025-10-25 | 2025-10-25 | Quarterly Result Announcement | NA | 8.11% |
| 2025-08-25 | 2025-08-25 | Annual General Meeting | NA | 13.66% |
| 2025-07-18 | 2025-07-18 | Quarterly Result Announcement | NA | -7.67% |
| 2025-05-23 | 2025-05-23 | Extraordinary General Meeting | NA | -1.25% |
| 2025-04-26 | 2025-04-26 | Quarterly Result Announcement | NA | 27.43% |
| 2025-01-06 | 2025-01-06 | Quarterly Result Announcement | NA | -0.04% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -2.06% |
| 2024-09-21 | 2024-09-21 | Annual General Meeting | NA | 57.70% |
| 2022-08-10 | 2022-08-10 | Change Of Name | NA | 0.00% |
Samsrita Labs Competitors Screener - Peer Stocks Comparison
Screen SAMSRITA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 32,813 | 59.65 | 2,864 | 12.11% | 510 | 56.98 |
| Vijaya Diagnostic Centre | 15,333 | 82.40 | 835 | 19.34% | 173 | 51.12 |
| Metropolis Healthcare | 11,814 | 58.51 | 1,671 | 24.15% | 191 | 45.27 |
| Thyrocare Technologies | 8,722 | 49.67 | 846 | 20.48% | 163 | 40.92 |
| Nephrocare Health Services | 6,717 | 79.69 | 1,023 | 32.93% | 77 | 37.77 |
| Suraksha Diagnostic | 1,806 | 51.63 | 314 | 22.55% | 31 | 61.81 |
| Krsnaa Diagnostics | 1,726 | 17.83 | 816 | 9.90% | 101 | 41.10 |
| 3B BlackBio DX | 1,351 | 24.11 | 142 | 27.17% | 61 | 66.56 |
| One Global Service Provider | 1,045 | 14.38 | 499 | 237.48% | 70 | 49.71 |
| Health X Platform | 890 | -34.21 | 1,319 | 12.68% | -3 | 38.00 |
Samsrita Labs Company Announcements - News & Reports Screener
Screen SAMSRITA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated October 2, 2026 and August 14, 2026.
| Date | Update | Actions |
|---|---|---|
| Board Meeting Outcome for Outcome Of Board Meeting Held On 28.09.2026 | - | |
| 2026-10-02 | Closure of Trading Window | - |
| 2026-08-14 | Announcement Under Regulation 30 (LODR) - Newspaper Publication | - |
| 2026-08-13 | Statement Of Deviation Or Variation For The Quarter Ended 30.06.2026 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13.08.2026 | - |
| 2026-08-13 | Un-Audited Financial Results For The Quarter Ended 30.06.2026 | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-05 | Board Meeting Intimation for Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2026 | - |
| 2026-07-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-18 | Reg. 34 (1) Annual Report. | - |
| 2026-07-18 | Notice Of AGM For The FY 2025-26 Scheduled To Be Held On 10.08.2026 | - |
| 2026-07-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-08 | Update On The Outcome Of Board Meeting Held On 04.07.2026 | - |
| 2026-07-07 | Update On The Outcome Of Board Meeting Held On 04.07.2026 | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-04 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-04 | Corporate Action-Outcome of Capital Reduction | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹11.35, within a 52-week range of ₹10.60 to ₹24.31. The P/E ratio is -3.29 and the P/B ratio is 2.28, with earnings per unit of ₹-3.99. Market capitalisation stands at ₹26.80 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.